182 related articles for article (PubMed ID: 3838343)
1. Cyclophosphamide versus 5-fluorouracil, doxorubicin, and mitomycin C (FAM') in the treatment of hormone-resistant metastatic carcinoma of the prostate: a preliminary report of a randomized trial.
Kasimis BS; Miller JB; Kaneshiro CA; Forbes KA; Moran EM; Metter GE
J Clin Oncol; 1985 Mar; 3(3):385-92. PubMed ID: 3838343
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hormone-resistant metastatic carcinoma of the prostate with 5-FU, doxorubicin, and mitomycin (FAM'): a preliminary report.
Kasimis BS; Moran EM; Miller JB; Forbes KA; Kaneshiro CA; Poblet MT; Williams JL
Cancer Treat Rep; 1983 Oct; 67(10):937-9. PubMed ID: 6688755
[TBL] [Abstract][Full Text] [Related]
3. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
Kim NK; Park YS; Heo DS; Suh C; Kim SY; Park KC; Kang YK; Shin DB; Kim HT; Kim HJ
Cancer; 1993 Jun; 71(12):3813-8. PubMed ID: 8508349
[TBL] [Abstract][Full Text] [Related]
4. 5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary.
Goldberg RM; Smith FP; Ueno W; Ahlgren JD; Schein PS
J Clin Oncol; 1986 Mar; 4(3):395-9. PubMed ID: 3754004
[TBL] [Abstract][Full Text] [Related]
5. The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
De Lisi V; Cocconi G; Angelini F; Cavicchi F; Di Costanzo F; Gilli G; Rodinò C; Soldani M; Tonato M; Finardi C
Cancer; 1996 Jan; 77(2):245-50. PubMed ID: 8625230
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of advanced gastric carcinoma (stage IV): a randomized study of FAM versus 5-FU plus BCNU.
Villar A; Asensio F; Candel M; Delgado F; Garcia J; Lledó S; Redón J; Roig JV; Sanchez A; Sanchis C
Chemioterapia; 1987 Feb; 6(1):57-62. PubMed ID: 3103932
[TBL] [Abstract][Full Text] [Related]
7. A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer.
Krook JE; Jett JR; Fleming TR; Dalton RJ; Marschke RF; Cullinan SA; Windschitl HE; Everson LK; Brunk FS; Laurie JA
J Clin Oncol; 1985 Jun; 3(6):842-8. PubMed ID: 3839263
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).
Oster MW; Gray R; Panasci L; Perry MC
Cancer; 1986 Jan; 57(1):29-33. PubMed ID: 2934124
[TBL] [Abstract][Full Text] [Related]
9. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
Cullinan SA; Moertel CG; Fleming TR; Rubin JR; Krook JE; Everson LK; Windschitl HE; Twito DI; Marschke RF; Foley JF
JAMA; 1985 Apr; 253(14):2061-7. PubMed ID: 2579257
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil, doxorubicin and mitomycin C (FAM) combination chemotherapy for metastatic adenocarcinoma of unknown primary.
van der Gaast A; Verweij J; Planting AS; Stoter G
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):765-8. PubMed ID: 3383976
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil.
Laurie JA; Hahn RG; Therneau TM; Patel SR; Mailliard JA; Windschitl HE; Twito DI; Morton RF; Krook JE
Cancer; 1992 Mar; 69(6):1440-4. PubMed ID: 1540881
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas.
Sulkes A; Uziely B; Isacson R; Brufman G; Biran S
Isr J Med Sci; 1988; 24(9-10):604-10. PubMed ID: 3204009
[TBL] [Abstract][Full Text] [Related]
13. 5-fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy in advanced adenocarcinoma of the lung: comparison of two dosage schedules.
Lam WK; So SY; Kung TM; Sham MK; Ip M
Cancer Chemother Pharmacol; 1987; 19(3):269-71. PubMed ID: 3107849
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) in the treatment of inoperable adenocarcinoma of the lung.
Shepherd FA; Evans WK; Burkes R; Paul K; DeBoer G
Am J Clin Oncol; 1986 Oct; 9(5):392-6. PubMed ID: 3776901
[TBL] [Abstract][Full Text] [Related]
15. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
J Clin Oncol; 1986 Dec; 4(12):1794-8. PubMed ID: 2946815
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of combination chemotherapy in hormone-resistant metastatic prostate carcinoma.
Page JP; Levi JA; Woods RL; Tattersall MN; Fox RM; Coates AS
Cancer Treat Rep; 1985 Jan; 69(1):105-7. PubMed ID: 3881176
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma.
Gibson MK; Holcroft CA; Kvols LK; Haller D
Oncologist; 2005 Feb; 10(2):132-7. PubMed ID: 15709215
[TBL] [Abstract][Full Text] [Related]
18. 5-Fluorouracil, doxorubicin (adriamycin) and mitomycin-C (FAM) in advanced gastric cancer: observations on response, patient characteristics, myelosuppression and delivered dosage.
Biran H; Sulkes A; Biran S
Oncology; 1989; 46(2):83-7. PubMed ID: 2710481
[TBL] [Abstract][Full Text] [Related]
19. OK-432 and 5-fluorouracil, doxorubicin, and mitomycin C (FAM-P) versus FAM chemotherapy in patients with curatively resected gastric carcinoma: a randomized Phase III trial.
Kim SY; Park HC; Yoon C; Yoon HJ; Choi YM; Cho KS
Cancer; 1998 Nov; 83(10):2054-9. PubMed ID: 9827708
[TBL] [Abstract][Full Text] [Related]
20. Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, Adriamycin (doxorubicin), and mitomycin C (modified FAM).
Haim N; Epelbaum R; Cohen Y; Robinson E
Cancer; 1984 Nov; 54(9):1999-2002. PubMed ID: 6548173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
